Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 8;11:4171–4184. doi: 10.2147/CMAR.S176937

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Ding et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Forest plot of the combined overall survival (OS) for (A1) bladder cancer patients; (A2) patients with organ-confined BC; analyzed with multivariate analysis, with PD-L1 status defined by TCs and OS (B1) without and (B2) with anti-PD-1/PD-L1 treatment in urothelial carcinoma patients with PD-L1 status stratified by ICs.

Abbreviations: OS, overall survival; BC, bladder cancer; TCs, tumor cells; PD-L1, programmed cell death ligand 1; ICs, tumor-infiltrating immune cells.